Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Lessened by Woodstock Corp

Woodstock Corp cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 87,007 shares of the medical equipment provider’s stock after selling 211 shares during the quarter. Intuitive Surgical accounts for 4.4% of Woodstock Corp’s portfolio, making the stock its 4th largest position. Woodstock Corp’s holdings in Intuitive Surgical were worth $45,414,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Godsey & Gibb Inc. boosted its stake in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the fourth quarter worth about $36,000. Mark Sheptoff Financial Planning LLC acquired a new position in Intuitive Surgical in the second quarter worth about $37,000. Finally, Capital Performance Advisors LLP bought a new stake in Intuitive Surgical in the third quarter valued at about $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $584.08 on Friday. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $585.50. The business has a fifty day moving average of $538.34 and a 200-day moving average of $497.08. The stock has a market cap of $208.04 billion, a price-to-earnings ratio of 93.90, a PEG ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the sale, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. The trade was a 26.54 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jamie Samath sold 22,903 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. This represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 48,190 shares of company stock valued at $25,012,927. Company insiders own 0.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Royal Bank of Canada boosted their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Citigroup increased their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Finally, Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.